Atkinson S H
Health Aff (Millwood). 1994 Summer;13(3):159-75. doi: 10.1377/hlthaff.13.3.159.
This paper briefly reviews university/industry licensing and research collaborations and focuses on three university-affiliated venture capital funds, which represent the most direct participation by academic institutions in creating new ventures based on technologies invented by their faculty members. The paper provides an early perspective on these funds as mechanisms for bringing new biomedical technologies into use. Although the new models have not existed long enough to fully evaluate their effectiveness, the early evidence is sufficient to suggest helpful guidelines for development of more efficient initiatives in the future.
本文简要回顾了大学与产业界的许可协议及研究合作情况，并重点关注了三只与大学相关的风险投资基金，它们代表了学术机构在基于其教员发明的技术创建新企业方面最直接的参与。本文对这些基金作为将新的生物医学技术投入使用的机制提供了早期观点。尽管这些新模式存在的时间还不够长，无法充分评估其有效性，但早期证据足以提出有助于未来开发更高效举措的指导方针。
